Militia Capital Partners LP Buys 5,800 Shares of Danaher Corporation $DHR

Militia Capital Partners LP raised its stake in Danaher Corporation (NYSE:DHR) by 1,933.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,100 shares of the conglomerate’s stock after buying an additional 5,800 shares during the quarter. Militia Capital Partners LP’s holdings in Danaher were worth $1,396,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of DHR. JPL Wealth Management LLC bought a new position in Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher in the third quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher in the fourth quarter valued at approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $181.57 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $180.54 and its 200-day simple moving average is $203.94. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $128.51 billion, a PE ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

A number of brokerages have recently commented on DHR. Guggenheim cut their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. cut their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. The Goldman Sachs Group cut their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.